Interpace Biosciences, Inc.
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2010 | — | $69.5M | $62.7M |
| FY2011 | — | $59.5M | $64.3M |
| FY2012 | — | $35.6M | $52.8M |
| FY2013 | — | $32.5M | $45.6M |
| FY2014 | $27.2M | $25.3M | $23.1M |
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2010 | — | $69.5M | $62.7M |
| FY2011 | — | $59.5M | $64.3M |
| FY2012 | — | $35.6M | $52.8M |
| FY2013 | — | $32.5M | $45.6M |
| FY2014 | $27.2M | $25.3M | $23.1M |